Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
4DMT completes enrollment in 4FRONT-2, global phase 3 trial of 4D-150 in wet AMD
2
FDA grants priority review to Satralizumab sBLA for thyroid eye disease
3
REGENXBIO doses first patient in NAAVIGATE, phase 2b/3 sura-vec trial for diabetic retinopathy
4
Dipanjan Pan, PhD, on early-stage tear biosensor research, closed-loop drug delivery, and the road to FDA clearance
5